Comparing the Effects of <i>Ganoderma lucidum</i> and Kombucha Mushrooms on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial

This randomized clinical trial compared the effects of <i>Ganoderma lucidum</i> and kombucha mushrooms on glycemic control in patients with type 2 diabetes. After the intervention, there were significant differences among the <i>G. lucidum</i>, kombucha mushroom, and control groups in fasting blood glucose, 2-hour postprandial glucose, and A1C. In the <i>G. lucidum</i> and kombucha mushroom groups, these measures all decreased significantly from baseline to after the intervention. The use of both <i>G. lucidum</i> and kombucha mushrooms was effective in glycemic control, and there was no significant difference in effectiveness between the two. Further studies of different doses and longer follow-up periods may clarify the best use of these substances.